Announcements Trials
Browse Landscape

Phase

Phase NA 44Phase 1/2 5Phase 1 5Phase 2 3Phase 4 1Phase 3 1Phase 2/3 1

Status

Recruiting 5Completed 5Unknown 3Withdrawn 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 157Neoplasms 115Colorectal Neoplasms 97Breast Neoplasms 90Pancreatic Neoplasms 81Leukemia, Myeloid, Acute 81Recurrence 78Neoplasm Metastasis 78Prostatic Neoplasms 73Melanoma 73Ovarian Neoplasms 72Multiple Myeloma 66Stomach Neoplasms 60Squamous Cell Carcinoma of Head and Neck 55Lung Neoplasms 55Triple Negative Breast Neoplasms 50Glioblastoma 48Lymphoma 47Endometrial Neoplasms 43Carcinoma, Hepatocellular 43Advanced Solid Tumor 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Lymphoma, Non-Hodgkin 41Advanced Solid Tumors 37Uterine Cervical Neoplasms 35Small Cell Lung Carcinoma 35Carcinoma, Renal Cell 34Lymphoma, Large B-Cell, Diffuse 32Lymphoma, B-Cell 32Sarcoma 29

Interventions

tislelizumab 1pembrolizumab 1Interleukin-15 1Bevacizumab 13-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × Disease × Clear all
NCT06726161 2026-04-13

GPC3

RayzeBio, Inc.

Phase 1/2 Recruiting
590 enrolled
Gastrointestinal

Disease, Carcinoma, Hepatocellular

NCT07508852 2026-04-02

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

Peking University First Hospital

Phase 1/2 Recruiting
30 enrolled
Thoracic

Disease, Small Cell Lung Carcinoma

NCT07410676 2026-02-18

EBNK-ST-001

Essen Biotech

Phase 1/2 Recruiting
83 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Bronchogenic, Disease, Esophageal Neoplasms, Glioblastoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT06007092 2025-12-01

HPVDCVax

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting
24 enrolled

Disease

NCT07244705 2025-11-24

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Anbogen Therapeutics, Inc.

Phase 1/2 Recruiting
66 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡